D A Berry

Decision analysis and Bayesian methods in clinical trials.

D A Berry, 1995, Cancer treatment and research.

A case for Bayesianism in clinical trials.

D A Berry, D. Berry, Donald A. Berry, 1993, Statistics in medicine.

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B.

D A Berry, D. Berry, L. Norton, 1998, Journal of the National Cancer Institute.

Statistical inference and the design of clinical trials.

D A Berry, D. Berry, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Association of angiogenesis in lymph node metastases with outcome of breast cancer.

Anthony J. Guidi, D A Berry, D. Berry, 2000, Journal of the National Cancer Institute.

Decision making during a phase III randomized controlled trial.

D A Berry, D. Berry, M C Wolff, 1994, Controlled clinical trials.

One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach.

D A Berry, D. Berry, C H Ho, 1988, Biometrics.

Cancer genomics: promises and complexities.

K R Coombes, D A Berry, D. Berry, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Logarithmic transformations in ANOVA.

D A Berry, D. Berry, 1987, Biometrics.

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.

D A Berry, D. Berry, L. Norton, 1998, Journal of the National Cancer Institute.

Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.

S L George, D A Berry, D. Berry, 1994, Statistics in medicine.